The Parkinson’s non-oral therapy pathway was originally launched in 2016, in order to clarify the complex access to non-oral treatments for Parkinson’s disease such as apomorphine, duodopa and deep brain stimulation. Now, an update to the pathway includes a new overview schematic which highlights the Parkinson’s…
— Read on neurologyacademy.org/articles/brand-new-elements-in-update-of-parkinsons-non-oral-therapy-pathway